Preparation method of 2-arylnitrile-thiazole derivative

An aryl nitrile thiazole and derivative technology, applied in the direction of zinc organic compounds, organic chemistry, etc., can solve the problems of high cost, unsuitable for industrial amplification, pollution, etc., and achieve the effects of mild conditions, short steps and cheap raw materials

Active Publication Date: 2014-07-09
SUNSHINE LAKE PHARM CO LTD
View PDF14 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This invention provides an efficient way for producing chemicals with fewer negative side-effects than traditional methods such as burning coal or oil at very low temperatures.

Problems solved by technology

This patented technical problem addressed in this patent relates to improving methods for producing chemical substances called guaazoones due to their ability to reduce urinary nitrosis without causing harmful side effects like excessively elevating levels of serum creature values. Existing techniques involve complicated procedures involving multiple steps, leading to increased costs associated therewith environmental concerns.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of 2-arylnitrile-thiazole derivative
  • Preparation method of 2-arylnitrile-thiazole derivative
  • Preparation method of 2-arylnitrile-thiazole derivative

Examples

Experimental program
Comparison scheme
Effect test

reference example 1

[0083] Reference Example 1 5-iodo-2-isobutoxybenzonitrile

[0084] 2-Methyl-1-propanol (1.11g, 15.1mmol) was dissolved in N,N-dimethylformamide (20mL), cooled to 0°C, and sodium hydride (0.6g, 15.1mmol, 60% dispersed in mineral oil). After the mixture was stirred at 0°C for 30 minutes, 2-fluoro-5-iodobenzonitrile (2.5 g, 10.1 mmol) was added thereto, returned to room temperature, and stirred overnight. After the reaction was completed, it was quenched with water (30 mL), and extracted with ethyl acetate (100 mL x 3). The combined organic phases were dried over anhydrous sodium sulfate, filtered, concentrated, and purified by column chromatography (petroleum ether:ethyl acetate (v / v)=40:1) to obtain the title compound as a yellow liquid (2.7g, 90%) .

[0085] 1 H NMR (400MHz, CDCl 3 )δ(ppm):1.05(d,6H,J=6.7Hz),2.12-2.19(m,1H),3.80(d,2H,J=6.5Hz),6.72(d,1H,J=8.9Hz) ,7.77(dd,1H,J=2.2,8.9Hz),7.80(d,1H,J=2.2Hz).

Embodiment 1

[0086] Example 1 2-zinc bromide-4-methylthiazole-5-ethyl carboxylate

[0087] Under anhydrous and oxygen-free conditions, zinc powder (325mg, 5mmol) and 1,2-dibromoethane (94mg, 0.5mmol) were mixed, and N,N-dimethylformamide (10mL) was added thereto . After the mixture was stirred at reflux for 0.5 hours, it was cooled to room temperature, and trimethylchlorosilane (65 mg, 0.6 mmol) and 5-iodo-2-isobutoxybenzonitrile (602 mg, 2 mmol) were sequentially added thereto. The reaction solution was heated up to 85°C, stirred for 7 hours, cooled, and used directly for the next reaction.

Embodiment 2

[0088] Example 2 Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

[0089]Under anhydrous and oxygen-free conditions, the above-prepared mixture was added to ethyl 2-bromo-4-methylthiazole-5-carboxylate (249mg, 1mmol) and Pd(PPh 3 ) 4 (116mg, 0.1mmol) in the mixture. Stir at room temperature and monitor the reaction by TLC. After the reaction, brine (20 mL) was added, and extracted with ethyl acetate (100 mL x 3). The combined organic phases were dried over anhydrous sodium sulfate, filtered, concentrated, and purified by column chromatography (petroleum ether:ethyl acetate (v / v)=10:1) to give the title compound as a white solid (0.21g, 61%) .

[0090] 1 H NMR (400MHz, CDCl 3 )δ(ppm):1.09(d,6H,J=6.7Hz),1.39(t,3H,J=7.2Hz),2.17-2.24(m,1H),2.76(s,3H),3.90(d, 2H,J=6.5Hz),4.35(q,2H,J=7.2Hz),7.00(d,1H,J=8.9Hz),8.09(dd,1H,J=2.2,8.9Hz),8,17( d,1H,J=2.2Hz).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a novel intermediate (II) and a method for preparing a 2-arylnitrile-thiazole derivative (I) by a coupling reaction of the novel intermediate (II) and a compound shown in the formula (III). In the formulas, X represents Cl, Br or I, Y represents F, Cl, Br, I, N2, -OSO2Ra, -OCORa or -OSi(Ra)3, R1 represents C1-6 alkyl or C6-10 aryl, Ra represents C1-6 alkyl or C6-10 aryl, and the C1-6 alkyl or C6-10 aryl is independently and optionally replaced. The preparation method has the advantages of mild technical conditions, less impurities, simple processes, safety and controllability and low energy consumption and is especially suitable for industrial production. The invention also discloses a method for preparing the novel intermediate shown in the formula (II). The preparation method utilizes cheap materials, is free of separation purification and greatly reduces a reaction cost.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner SUNSHINE LAKE PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products